000 | 01469 a2200409 4500 | ||
---|---|---|---|
005 | 20250518000710.0 | ||
264 | 0 | _c20200316 | |
008 | 202003s 0 0 eng d | ||
022 | _a1522-9653 | ||
024 | 7 |
_a10.1016/j.joca.2018.08.022 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Windt, T S | |
245 | 0 | 0 |
_aEthics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials. _h[electronic resource] |
260 |
_bOsteoarthritis and cartilage _c01 2019 |
||
300 |
_a34-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEthics, Research |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInformed Consent _xethics |
650 | 0 | 4 |
_aMusculoskeletal Diseases _xtherapy |
650 | 0 | 4 |
_aPatient Selection _xethics |
650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xethics |
650 | 0 | 4 |
_aRegenerative Medicine _xethics |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 |
_aStem Cell Transplantation _xethics |
700 | 1 | _aNiemansburg, S L | |
700 | 1 | _aVonk, L A | |
700 | 1 | _avan Delden, J M | |
700 | 1 | _aRoes, K C B | |
700 | 1 | _aDhert, W J A | |
700 | 1 | _aSaris, D B F | |
700 | 1 | _aBredenoord, A L | |
773 | 0 |
_tOsteoarthritis and cartilage _gvol. 27 _gno. 1 _gp. 34-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.joca.2018.08.022 _zAvailable from publisher's website |
999 |
_c28863597 _d28863597 |